Main Article Content
breakthrough COVID-19 infection, interstitial pneumonia, organization of care, COVID-19 vaccine
After the implementation of mass vaccination campaigns, breakthrough infections by SARS-CoV-2 are being increasingly observed worldwide, due to high pervasiveness of viral spread, emergence of novel variants, progressive ease of restrictive measures and waning protection against infection. Although breakthrough infections have generally lower clinical severity than COVID-19 in unvaccinated subjects, a consistent number of patients may still require hospitalization. These patients are generally old, frail and with a high number of comorbidities. Despite COVID-19-related symptoms are generally milder, they may still exhibit complicated clinical course for their intrinsic clinical complexity. The organization of hospital care should thus consider the changing epidemiology of patients admitted with SARS-CoV-2 infection in the post-vaccine era, to improve the quality and appropriateness of care.
2. Fiolet T, Kherabi Y, MacDonald CJ, et al. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect 2021; ahead of print Oct 26. https://doi.org/10.1016/j.cmi.2021.10.005.
3. Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med 2021;385(7):585-594.
4. Agrawal U, Katikireddi SV, McCowan C, et al. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2.57 million people in Scotland (EAVE II): a prospective cohort study. Lancet Respir Med 2021; ahead of print Sep 29. https://doi.org/10.1016/S2213-2600(21)00380-5.
5. Juthani PV, Gupta A, Borges KA, et al. Hospitalisation among vaccine breakthrough COVID-19 infections. Lancet Infect Dis 2021;21(11):1485-1486.
6. Altmann DM, Boyton RJ. Waning immunity to SARS-CoV-2: implications for vaccine booster strategies. Lancet Respir Med 2021; ahead of print Oct 21. https://doi.org/10.1016/S2213-2600(21)00458-6.
7. Barda N, Dagan N, Cohen C, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet 2021; ahead of print Oct 29. https://doi.org/10.1016/S0140-6736(21)02249-2.
8. Soiza RL, Scicluna C, Thomson EC. Efficacy and safety of COVID-19 vaccines in older people. Age Ageing 2021;50(2):279-283.
9. Butt AA, Nafady-Hego H, Chemaitelly H, et al. Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination. Int J Infect Dis 2021;110:353-358.
10. Tenforde MW, Self WH, Adams K, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA 2021; ahead of print Nov 4. https://doi.org/10.1001/jama.2021.19499.
11. Ticinesi A, Nouvenne A, Cerundolo N, et al. Trends of COVID-19 Admissions in an Italian Hub during the Pandemic Peak: Large Retrospective Study Focused on Older Subjects. J Clin Med 2021; 10(5):1115.
12. Nouvenne A, Caminiti C, Diodati F, et al. Implementation of a strategy involving a multidisciplinary mobile unit team to prevent hospital admission in nursing home residents: protocol of a quasi-experimental study (MMU-1 study). BMJ Open 2020;10(2):e034742.
13. Nouvenne A, Zani MD, Milanese G, et al. Lung ultrasound in COVID-19 pneumonia: correlations with chest CT on hospital admission. Respiration 2020;99(7):617-624.
14. Corazza GR, Formagnana P, Lenti MV. Bringing complexity into clinical practice: an internistic approach. Eur J Intern Med 2019;61:9-14.
15. Lenti MV, Corazza GR, Di Sabatino A. Carving out a place for internal medicine during COVID-19 pandemic in Italy. J Intern Med 2020;288(2):263-265.
16. Corrao S, Natoli G, Nobili A, et al. Comorbidity does not mean clinical complexity: evidence from the RePoSI register. Intern Emerg Med 2020;15(4):621-628.
17. Meschi T, Rossi S, Volpi A, et al. Reorganization of a large academic hospital to face COVID-19 outbreak: The model of Parma, Emilia-Romagna region, Italy. Eur J Clin Invest 2020;50(6):e13250.
18. Meschi T, Ticinesi A, Prati B, et al. A novel organizational model to face the challenge of multimorbid elderly patients in an internal medicine setting: a case study from Parma Hospital, Italy. Intern Emerg Med 2016;11(5):667-676.
19. Liguori I, Russo G, Aran L, et al. Acute care hospital at different levels of intensity: the role of Geriatrician. Aging Clin Exp Res 2018;30(7):703-712.